Yield10 Bioscience
YTEN
#10713
Rank
A$0.5 M
Marketcap
A$0.49
Share price
0.00%
Change (1 day)
-83.07%
Change (1 year)
Categories

Earnings for Yield10 Bioscience (YTEN)

Earnings in 2024 (TTM): -A$19.23 Million

According to Yield10 Bioscience's latest financial reports the company's current earnings are A$0.81 Million. In 2023 the company made an earning of -A$20.99 Million a decrease over its 2022 earnings that were of -A$19.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Yield10 Bioscience from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$19.23 Million-8.38%
2023 -A$20.99 Million7.79%
2022 -A$19.47 Million21.96%
2021 -A$15.97 Million8.33%
2020 -A$14.74 Million-23.16%
2019 -A$19.18 Million43.85%
2018 -A$13.34 Million-2.27%
2017 -A$13.65 Million-8.65%
2016 -A$14.94 Million-50.87%
2015 -A$30.4 Million-21.78%
2014 -A$38.86 Million-10.01%
2013 -A$43.19 Million-919.48%
2012 A$5.26 M-109.35%
2011 -A$56.36 Million-0.31%
2010 -A$56.53 Million0.54%
2009 -A$56.23 Million-0.42%
2008 -A$56.46 Million15.01%
2007 -A$49.09 Million92.96%
2006 -A$25.44 Million149.46%
2005 -A$10.2 Million40.49%
2004 -A$7.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-A$3.14 Million-82.99% Bahamas
NRC Health
NRC
A$40.02 M-317.08%๐Ÿ‡บ๐Ÿ‡ธ USA